查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2128041

臨床試驗材料市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測。

Clinical Trial Supplies Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 2-3個工作天內

價格

臨床試驗材料市場成長要素

受臨床試驗數量增加、製藥和生物技術領域研發活動活性化以及分散式和混合臨床試驗模式的日益普及等因素的推動，全球臨床試驗材料市場正經歷強勁成長。報告顯示，2025年全球臨床試驗材料市場規模為54.5億美元。預計該市場將從2026年的58.3億美元成長至2034年的118億美元，預測期內複合年成長率（CAGR）為9.2%。北美市場佔主導地位，預計2025年市場佔有率將達到38.16%，這主要得益於該地區製藥公司的高度集中、先進的臨床研究基礎設施以及藥物研發投入的增加。

臨床試驗材料包括臨床實驗藥物、對照藥物和輔助材料，以及包裝、標籤、儲存、冷鏈物流、庫存管理和配送等專業服務。這些材料確保臨床試驗安全、有效率、合規地進行，並在整個研究過程中維護產品品質和病人安全。

市場定義和範圍

臨床試驗材料在支援製藥、生物技術和醫療設備研發方面發揮著至關重要的作用，確保臨床實驗藥物安全且有效率地送達研究中心和患者手中。供應管理涵蓋生產支援、包裝、貼標、盲法、溫控儲存、物流、儲存場所管理以及直接送達病患（DTP）服務。

該市場涵蓋生技藥品、小分子藥物、醫療設備、細胞和基因療法以及其他先進療法的臨床試驗。由於供應鏈管理外包給專業服務供應商的趨勢日益成長，該市場在全球範圍內持續擴張。

市場動態

成長要素

全球臨床試驗數量的持續成長仍然是市場成長的主要驅動力。製藥、生技和醫療設備公司持續加大研發投入，以期在腫瘤學、循環系統、感染疾病、神經病學及其他治療領域推出創新療法。這顯著提升了對可靠的臨床試驗供應鏈管理服務的需求。

另一個主要的成長要素是分散式和混合式臨床試驗的快速普及。直接面向患者（DTP）、數位化庫存管理、溫度監控和即時供應鏈追蹤等技術的廣泛應用，在提高營運效率的同時，也增加了患者入組率和試驗的準確性。

趨勢

市場最重要的趨勢之一是將數位技術和自動化融入臨床試驗供應鏈。電子資料採集 (EDC)、基於雲端的庫存管理系統、RTSM/IRT 平台、ePRO 解決方案以及人工智慧驅動的物流管理正在幫助申辦方提高庫存可見度、最大限度地減少浪費並最佳化全球臨床試驗營運。

此外，以患者為中心的供應模式，如遠端配藥、宅配和數位責任制系統，正變得越來越普遍，提高了參與者的便利性，並支持了分散的臨床研究。

阻礙因素

高昂的營運成本仍是臨床試驗藥物供應市場的主要阻礙因素。特殊包裝、冷鏈運輸、儲存、法規遵循、進出口文件、庫存預測以及溫控物流等都顯著增加了供應管理的總體成本。受試者招募的延遲和方案的修改進一步加劇了供應效率低下和產品浪費。

擴大臨床研究的影響

全球臨床研究的持續擴張，對高效的臨床試驗藥物供應服務產生了強勁的需求。生技藥品、生物相似藥、個人化醫療以及細胞和基因療法的投資不斷增加，需要高度專業的物流和供應鏈解決方案。同時，新興經濟體臨床研究基礎設施的不斷完善，也為全球供應商創造了更多商機。

細分分析

就服務類型而言，受包裝、貼標、倉儲、配送、原廠藥採購、倉庫管理以及直接面向患者（DTP）服務外包需求增加的推動，服務部門在2025年主導市場。產品部門預計在預測期內也將保持穩定成長。

按階段分類，在全球後期藥物研發活動增加的支持下，預計到 2025 年，III 期臨床試驗將佔最大的市場佔有率，達到 51.4%。

按治療方法分類，小分子藥物預計到2025年將佔最大的市場佔有率，達到44.1%，這主要得益於獲批藥物數量的增加和相對簡單的生產過程。醫療設備預計在預測期內也將顯著成長。

依治療領域分類，腫瘤學仍是最大的細分領域，這主要得益於癌症盛行率的上升和抗癌藥物研發投入的增加。

按最終用戶分類，由於研發支出增加和全球臨床試驗數量上升，製藥和生物技術公司佔了市場主導地位。

區域分析

預計北美將引領全球臨床試驗材料市場，到 2025 年市場規模將達到 20.8 億美元。該地區受益於先進的醫療保健基礎設施、大量的製藥公司以及活躍的臨床研究活動，尤其是在美國。

歐洲仍然是第二大區域市場，這得益於不斷增加的臨床試驗活動和促進藥物創新的健全法規結構。

由於中國、日本和印度醫療保健支出增加、藥品生產規模擴大以及臨床試驗活動增多，亞太地區預計將顯著成長。隨著醫療基礎設施和研發投入的持續改善，拉丁美洲和中東及非洲地區也逐漸擴張。

本報告對全球臨床試驗材料市場進行了全面分析，涵蓋了 2025 年、2026 年和 2034 年的市場規模和預測。報告詳細分析了市場促進因素、趨勢、限制因素、按類型、階段、方式、治療領域和最終用戶分類的市場細分、區域展望、競爭格局以及影響未來市場成長的最新發展。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
  • 市場趨勢

第4章：主要考慮因素

  • 臨床試驗數量，主要國家/地區，2025 年
  • 研發支出概覽，主要公司
  • 產業重大發展：合併、收購與合作。

第5章：2021-2034年全球臨床試驗材料市場分析、洞察與預測

  • 市場分析、洞察與預測：按類型
    • 服務
      • 製造服務
      • 包裝、貼標和封蓋服務
      • 倉儲和配送服務
      • 其他
  • 市場分析、洞察與預測：按階段分類
    • 第一階段
    • 第二階段
    • 第三階段
    • 第四階段
  • 市場分析、洞察與預測：按模式分類
    • 低分子化合物
    • 生物製劑
    • 醫療器材
    • 其他
  • 市場分析、洞察與預測：按治療領域分類
    • 腫瘤學
    • 感染疾病
    • 神經病學
    • 循環系統
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 製藥和生物技術公司
    • 醫療設備製造商
    • CRO
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美臨床試驗材料市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲臨床試驗材料市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區臨床試驗材料市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲臨床試驗材料市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲臨床試驗材料市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Parexel International（MA）Corporation
    • Catalent Inc.
    • Almac Group
    • PCI Pharma Services
    • Clinigen Limited
    • Myonex
    • Biocair
    • Oximio
    • KLIFO
Product Code: FBI111707

Growth Factors of clinical trial supplies Market

The global clinical trial supplies market is experiencing strong growth due to the increasing number of clinical studies, rising pharmaceutical and biotechnology research activities, and the growing adoption of decentralized and hybrid clinical trials. According to the report, the global clinical trial supplies market size was valued at USD 5.45 billion in 2025. The market is projected to grow from USD 5.83 billion in 2026 to USD 11.80 billion by 2034, exhibiting a CAGR of 9.2% during the forecast period. North America dominated the market with a 38.16% market share in 2025, driven by a high concentration of pharmaceutical companies, advanced clinical research infrastructure, and increasing investment in drug development.

Clinical trial supplies include investigational medicinal products, comparator drugs, ancillary supplies, and specialized services such as packaging, labeling, storage, cold-chain logistics, inventory management, and distribution. These supplies ensure the safe, efficient, and compliant execution of clinical trials while maintaining product quality and patient safety throughout the research process.

Market Definition and Scope

Clinical trial supplies play a critical role in supporting pharmaceutical, biotechnology, and medical device research by ensuring investigational products reach trial sites and patients safely and efficiently. Supply management includes manufacturing support, packaging, labeling, blinding, temperature-controlled storage, logistics, depot management, and Direct-to-Patient (DTP) delivery services.

The market serves clinical trials across biologics, small molecules, medical devices, cell and gene therapies, and other advanced therapies. Increasing outsourcing of supply chain management to specialized service providers continues to expand the market scope globally.

Market Dynamics

Drivers

The growing number of clinical trials worldwide remains the primary driver of market growth. Pharmaceutical, biotechnology, and medical device companies continue investing heavily in research and development to introduce innovative therapies across oncology, cardiology, infectious diseases, neurology, and other therapeutic areas. This significantly increases demand for reliable clinical trial supply management services.

Another major growth driver is the rapid adoption of decentralized and hybrid clinical trials. The increasing use of Direct-to-Patient (DTP) delivery, digital inventory management, temperature monitoring, and real-time supply tracking improves operational efficiency while enhancing patient participation and trial accuracy.

Trends

One of the most significant market trends is the integration of digital technologies and automation into clinical trial supply chains. Electronic data capture, cloud-based inventory systems, RTSM/IRT platforms, ePRO solutions, and AI-powered logistics management are helping sponsors improve inventory visibility, minimize wastage, and optimize global clinical trial operations.

Additionally, patient-centric supply models such as remote dispensing, home delivery, and digital accountability systems are becoming increasingly common, improving convenience for participants while supporting decentralized clinical research.

Restraints

High operational costs remain a key restraint for the clinical trial supplies market. Specialized packaging, cold-chain transportation, storage, regulatory compliance, import/export documentation, inventory forecasting, and temperature-controlled logistics significantly increase overall supply management costs. Delays in patient recruitment and protocol amendments further contribute to supply inefficiencies and product wastage.

Impact of Growing Clinical Research

The continuous expansion of global clinical research is creating strong demand for efficient clinical trial supply services. Increasing investment in biologics, biosimilars, personalized medicine, and cell & gene therapies requires highly specialized logistics and supply chain solutions. At the same time, emerging countries are strengthening clinical research infrastructure, creating additional opportunities for global supply providers.

Segmentation Analysis

By type, the services segment dominated the market in 2025 due to rising outsourcing of packaging, labeling, storage, distribution, comparator sourcing, depot management, and Direct-to-Patient (DTP) delivery services. The products segment is also expected to witness steady growth during the forecast period.

By phase, Phase III clinical trials accounted for the largest market share of 51.4% in 2025, supported by increasing late-stage drug development activities worldwide.

By modality, small molecules held the largest 44.1% market share in 2025, driven by growing approvals and relatively easier manufacturing processes. Medical devices are expected to record significant growth during the forecast period.

By therapeutic area, oncology remained the leading segment due to the increasing prevalence of cancer and rising investment in oncology drug development.

By end user, pharmaceutical and biotechnology companies dominated the market owing to growing R&D expenditure and the increasing number of global clinical trials.

Regional Insights

North America led the global clinical trial supplies market with a valuation of USD 2.08 billion in 2025. The region benefits from advanced healthcare infrastructure, a large number of pharmaceutical companies, and strong clinical research activities, particularly in the United States.

Europe remains the second-largest regional market, supported by increasing clinical trial activities and strong regulatory frameworks promoting pharmaceutical innovation.

Asia Pacific is expected to witness substantial growth due to rising healthcare expenditure, expanding pharmaceutical manufacturing, and increasing clinical trial activities across China, Japan, and India. Latin America and the Middle East & Africa are also experiencing gradual expansion as healthcare infrastructure and research investments continue to improve.

Competitive Landscape

The global clinical trial supplies market is highly competitive, with companies focusing on acquisitions, digital technologies, logistics expansion, and service innovation to strengthen their market position. Major industry participants include Thermo Fisher Scientific Inc., Parexel International (MA) Corporation, Catalent Inc., Almac Group, PCI Pharma Services, Clinigen Limited, Myonex, Biocair, Oximio, and KLIFO. Strategic acquisitions, AI-powered supply management platforms, and expansion of clinical logistics networks continue to enhance competition within the industry.

Report Coverage

This report provides a comprehensive analysis of the global clinical trial supplies market, covering market size and forecast for 2025, 2026, and 2034. It includes detailed insights into market drivers, trends, restraints, segmentation by type, phase, modality, therapeutic area, end user, regional outlook, competitive landscape, and recent industry developments influencing future market growth.

Conclusion

The global clinical trial supplies market is projected to grow from USD 5.45 billion in 2025 to USD 11.80 billion by 2034, driven by the increasing number of clinical trials, expanding pharmaceutical research, growing adoption of decentralized clinical studies, and continuous advancements in digital supply chain technologies. Rising investments in biologics, personalized medicine, and innovative clinical trial services are expected to support sustained market growth throughout the forecast period.

Segmentation By Type, Phase, Modality, Therapeutic Area, End User, and Region

By Type * Products

    • Investigational Medicinal Products
    • Comparator Drugs
    • Ancillary Supplies
    • Others
  • Services
    • Manufacturing Services
    • Packaging, Labeling & Blinding Services
    • Storage & Distribution Services
    • Others

By Phase * Phase I

  • Phase II
  • Phase III
  • Phase IV

By Modality * Small Molecules

  • Biologics
  • Medical Devices
  • Others

By Therapeutic Area * Oncology

  • Infectious Diseases
  • Neurology
  • Cardiology
  • Others

By End User * Pharmaceutical & Biotechnological Companies

  • Medical Device Companies
  • CROs
  • Others

By Region * North America (By Type, By Phase, By Modality, By Therapeutic Area, By End User, and by Country)

    • U.S. (By Phase)
    • Canada (By Phase)
  • Europe (By Type, By Phase, By Modality, By Therapeutic Area, By End User, and by Country/Sub-region)
    • U.K. (By Phase)
    • Germany (By Phase)
    • France (By Phase)
    • Italy (By Phase)
    • Spain (By Phase)
    • Scandinavia (By Phase)
    • Rest of Europe (By Phase)
  • Asia Pacific (By Type, By Phase, By Modality, By Therapeutic Area, By End User, and by Country/Sub-region)
    • China (By Phase)
    • Japan (By Phase)
    • India (By Phase)
    • Australia (By Phase)
    • Southeast Asia (By Phase)
    • Rest of Asia Pacific (By Phase)
  • Latin America (By Type, By Phase, By Modality, By Therapeutic Area, By End User, and by Country/Sub-region)
    • Brazil (By Phase)
    • Mexico (By Phase)
    • Rest of Latin America (By Phase)
  • Middle East & Africa (By Type, By Phase, By Modality, By Therapeutic Area, By End User, and by Country/Sub-region)
    • GCC (By Phase)
    • South Africa (By Phase)
    • Rest of the Middle East & Africa (By Phase)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Challenges
  • 3.5. Market Trends

4. Key Insights

  • 4.1. Number of Clinical Trials, Key Countries/Regions, 2025
  • 4.2. Overview of R&D Expenditures, Key Players
  • 4.3. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Clinical Trial Supplies Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Products
      • 5.1.1.1. Investigational Medicinal Products
      • 5.1.1.2. Comparator Drugs
      • 5.1.1.3. Ancillary Supplies
      • 5.1.1.4. Others
    • 5.1.2. Services
      • 5.1.2.1. Manufacturing Services
      • 5.1.2.2. Packaging, Labeling & Blinding Services
      • 5.1.2.3. Storage & Distribution Services
      • 5.1.2.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Phase
    • 5.2.1. Phase I
    • 5.2.2. Phase II
    • 5.2.3. Phase III
    • 5.2.4. Phase IV
  • 5.3. Market Analysis, Insights and Forecast - By Modality
    • 5.3.1. Small Molecules
    • 5.3.2. Biologics
    • 5.3.3. Medical Devices
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 5.4.1. Oncology
    • 5.4.2. Infectious Diseases
    • 5.4.3. Neurology
    • 5.4.4. Cardiology
    • 5.4.5. Others
  • 5.5. Market Analysis, Insights and Forecast - By End User
    • 5.5.1. Pharmaceutical & Biotechnological Companies
    • 5.5.2. Medical Device Companies
    • 5.5.3. CROs
    • 5.5.4. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Clinical Trial Supplies Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Products
      • 6.1.1.1. Investigational Medicinal Products
      • 6.1.1.2. Comparator Drugs
      • 6.1.1.3. Ancillary Supplies
      • 6.1.1.4. Others
    • 6.1.2. Services
      • 6.1.2.1. Manufacturing Services
      • 6.1.2.2. Packaging, Labeling & Blinding Services
      • 6.1.2.3. Storage & Distribution Services
      • 6.1.2.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Phase
    • 6.2.1. Phase I
    • 6.2.2. Phase II
    • 6.2.3. Phase III
    • 6.2.4. Phase IV
  • 6.3. Market Analysis, Insights and Forecast - By Modality
    • 6.3.1. Small Molecules
    • 6.3.2. Biologics
    • 6.3.3. Medical Devices
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 6.4.1. Oncology
    • 6.4.2. Infectious Diseases
    • 6.4.3. Neurology
    • 6.4.4. Cardiology
    • 6.4.5. Others
  • 6.5. Market Analysis, Insights and Forecast - By End User
    • 6.5.1. Pharmaceutical & Biotechnological Companies
    • 6.5.2. Medical Device Companies
    • 6.5.3. CROs
    • 6.5.4. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
      • 6.6.1.1. By Phase
    • 6.6.2. Canada
      • 6.6.2.1. By Phase

7. Europe Clinical Trial Supplies Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Products
      • 7.1.1.1. Investigational Medicinal Products
      • 7.1.1.2. Comparator Drugs
      • 7.1.1.3. Ancillary Supplies
      • 7.1.1.4. Others
    • 7.1.2. Services
      • 7.1.2.1. Manufacturing Services
      • 7.1.2.2. Packaging, Labeling & Blinding Services
      • 7.1.2.3. Storage & Distribution Services
      • 7.1.2.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Phase
    • 7.2.1. Phase I
    • 7.2.2. Phase II
    • 7.2.3. Phase III
    • 7.2.4. Phase IV
  • 7.3. Market Analysis, Insights and Forecast - By Modality
    • 7.3.1. Small Molecules
    • 7.3.2. Biologics
    • 7.3.3. Medical Devices
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 7.4.1. Oncology
    • 7.4.2. Infectious Diseases
    • 7.4.3. Neurology
    • 7.4.4. Cardiology
    • 7.4.5. Others
  • 7.5. Market Analysis, Insights and Forecast - By End User
    • 7.5.1. Pharmaceutical & Biotechnological Companies
    • 7.5.2. Medical Device Companies
    • 7.5.3. CROs
    • 7.5.4. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
      • 7.6.1.1. By Phase
    • 7.6.2. Germany
      • 7.6.2.1. By Phase
    • 7.6.3. France
      • 7.6.3.1. By Phase
    • 7.6.4. Spain
      • 7.6.4.1. By Phase
    • 7.6.5. Italy
      • 7.6.5.1. By Phase
    • 7.6.6. Scandinavia
      • 7.6.6.1. By Phase
    • 7.6.7. Rest of Europe
      • 7.6.7.1. By Phase

8. Asia Pacific Clinical Trial Supplies Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Products
      • 8.1.1.1. Investigational Medicinal Products
      • 8.1.1.2. Comparator Drugs
      • 8.1.1.3. Ancillary Supplies
      • 8.1.1.4. Others
    • 8.1.2. Services
      • 8.1.2.1. Manufacturing Services
      • 8.1.2.2. Packaging, Labeling & Blinding Services
      • 8.1.2.3. Storage & Distribution Services
      • 8.1.2.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Phase
    • 8.2.1. Phase I
    • 8.2.2. Phase II
    • 8.2.3. Phase III
    • 8.2.4. Phase IV
  • 8.3. Market Analysis, Insights and Forecast - By Modality
    • 8.3.1. Small Molecules
    • 8.3.2. Biologics
    • 8.3.3. Medical Devices
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 8.4.1. Oncology
    • 8.4.2. Infectious Diseases
    • 8.4.3. Neurology
    • 8.4.4. Cardiology
    • 8.4.5. Others
  • 8.5. Market Analysis, Insights and Forecast - By End User
    • 8.5.1. Pharmaceutical & Biotechnological Companies
    • 8.5.2. Medical Device Companies
    • 8.5.3. CROs
    • 8.5.4. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
      • 8.6.1.1. By Phase
    • 8.6.2. Australia
      • 8.6.2.1. By Phase
    • 8.6.3. China
      • 8.6.3.1. By Phase
    • 8.6.4. India
      • 8.6.4.1. By Phase
    • 8.6.5. Southeast Asia
      • 8.6.5.1. By Phase
    • 8.6.6. Rest of Asia Pacific
      • 8.6.6.1. By Phase

9. Latin America Clinical Trial Supplies Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Products
      • 9.1.1.1. Investigational Medicinal Products
      • 9.1.1.2. Comparator Drugs
      • 9.1.1.3. Ancillary Supplies
      • 9.1.1.4. Others
    • 9.1.2. Services
      • 9.1.2.1. Manufacturing Services
      • 9.1.2.2. Packaging, Labeling & Blinding Services
      • 9.1.2.3. Storage & Distribution Services
      • 9.1.2.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Phase
    • 9.2.1. Phase I
    • 9.2.2. Phase II
    • 9.2.3. Phase III
    • 9.2.4. Phase IV
  • 9.3. Market Analysis, Insights and Forecast - By Modality
    • 9.3.1. Small Molecules
    • 9.3.2. Biologics
    • 9.3.3. Medical Devices
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 9.4.1. Oncology
    • 9.4.2. Infectious Diseases
    • 9.4.3. Neurology
    • 9.4.4. Cardiology
    • 9.4.5. Others
  • 9.5. Market Analysis, Insights and Forecast - By End User
    • 9.5.1. Pharmaceutical & Biotechnological Companies
    • 9.5.2. Medical Device Companies
    • 9.5.3. CROs
    • 9.5.4. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
      • 9.6.1.1. By Phase
    • 9.6.2. Mexico
      • 9.6.2.1. By Phase
    • 9.6.3. Rest of Latin America
      • 9.6.3.1. By Phase

10. Middle East & Africa Clinical Trial Supplies Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Products
      • 10.1.1.1. Investigational Medicinal Products
      • 10.1.1.2. Comparator Drugs
      • 10.1.1.3. Ancillary Supplies
      • 10.1.1.4. Others
    • 10.1.2. Services
      • 10.1.2.1. Manufacturing Services
      • 10.1.2.2. Packaging, Labeling & Blinding Services
      • 10.1.2.3. Storage & Distribution Services
      • 10.1.2.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Phase
    • 10.2.1. Phase I
    • 10.2.2. Phase II
    • 10.2.3. Phase III
    • 10.2.4. Phase IV
  • 10.3. Market Analysis, Insights and Forecast - By Modality
    • 10.3.1. Small Molecules
    • 10.3.2. Biologics
    • 10.3.3. Medical Devices
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 10.4.1. Oncology
    • 10.4.2. Infectious Diseases
    • 10.4.3. Neurology
    • 10.4.4. Cardiology
    • 10.4.5. Others
  • 10.5. Market Analysis, Insights and Forecast - By End User
    • 10.5.1. Pharmaceutical & Biotechnological Companies
    • 10.5.2. Medical Device Companies
    • 10.5.3. CROs
    • 10.5.4. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
      • 10.6.1.1. By Phase
    • 10.6.2. South Africa
      • 10.6.2.1. By Phase
    • 10.6.3. Rest of Middle East & Africa
      • 10.6.3.1. By Phase

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Parexel International (MA) Corporation
    • 11.2.3. Catalent Inc.
    • 11.2.4. Almac Group
    • 11.2.5. PCI Pharma Services
    • 11.2.6. Clinigen Limited
    • 11.2.7. Myonex
    • 11.2.8. Biocair
    • 11.2.9. Oximio
    • 11.2.10. KLIFO

List of Tables

  • Table 1: Global Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 3: Global Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Services, 2021-2034
  • Table 4: Global Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 5: Global Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 6: Global Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021-2034
  • Table 7: Global Clinical Trial Supplies Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 8: Global Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 9: North America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 10: North America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 11: North America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Services, 2021-2034
  • Table 12: North America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 13: North America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 14: North America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021-2034
  • Table 15: North America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 16: North America Clinical Trial Supplies Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 17: U.S. Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 18: Canada Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 19: Europe Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 20: Europe Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 21: Europe Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Services, 2021-2034
  • Table 22: Europe Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 23: Europe Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 24: Europe Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021-2034
  • Table 25: Europe Clinical Trial Supplies Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 26: Europe Clinical Trial Supplies Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 27: Germany Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 28: U.K. Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 29: France Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 30: Italy Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 31: Spain Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 32: Scandinavia Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 33: Rest of Europe Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 34: Asia Pacific Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 35: Asia Pacific Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 36: Asia Pacific Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Services, 2021-2034
  • Table 37: Asia Pacific Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 38: Asia Pacific Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 39: Asia Pacific Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021-2034
  • Table 40: Asia Pacific Clinical Trial Supplies Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 41: Asia Pacific Clinical Trial Supplies Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 42: China Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 43: Japan Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 44: India Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 45: Australia Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 46: Southeast Asia Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 47: Rest of Asia Pacific Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 48: Latin America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 49: Latin America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 50: Latin America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Services, 2021-2034
  • Table 51: Latin America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 52: Latin America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 53: Latin America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021-2034
  • Table 54: Latin America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 55: Latin America Clinical Trial Supplies Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 56: Brazil Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 57: Mexico Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 58: Rest of Latin America Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 59: Middle East & Africa Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 60: Middle East & Africa Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 61: Middle East & Africa Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Services, 2021-2034
  • Table 62: Middle East & Africa Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 63: Middle East & Africa Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Modality, 2021-2034
  • Table 64: Middle East & Africa Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021-2034
  • Table 65: Middle East & Africa Clinical Trial Supplies Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 66: Middle East & Africa Clinical Trial Supplies Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 67: GCC Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 68: South Africa Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034
  • Table 69: Rest of Middle East & Africa Clinical Trial Supplies Market Revenue (USD billion) Forecast, by Phase, 2021-2034

List of Figures

  • Figure 1: Global Clinical Trial Supplies Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Clinical Trial Supplies Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Clinical Trial Supplies Market Value Share (%), by Phase, 2025 & 2034
  • Figure 4: Global Clinical Trial Supplies Market Value Share (%), by Modality, 2025 & 2034
  • Figure 5: Global Clinical Trial Supplies Market Value Share (%), by Therapeutic Area, 2025 & 2034
  • Figure 6: Global Clinical Trial Supplies Market Value Share (%), by End User, 2025 & 2034
  • Figure 7: Global Clinical Trial Supplies Market Value Share (%), by Region, 2025 & 2034
  • Figure 8: North America Clinical Trial Supplies Market Value (USD billion), by Type, 2025 & 2034
  • Figure 9: North America Clinical Trial Supplies Market Value Share (%), by Type, 2025
  • Figure 10: North America Clinical Trial Supplies Market Value (USD billion), by Phase, 2025 & 2034
  • Figure 11: North America Clinical Trial Supplies Market Value Share (%), by Phase, 2025
  • Figure 12: North America Clinical Trial Supplies Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 13: North America Clinical Trial Supplies Market Value Share (%), by Modality, 2025
  • Figure 14: North America Clinical Trial Supplies Market Value (USD billion), by Therapeutic Area, 2025 & 2034
  • Figure 15: North America Clinical Trial Supplies Market Value Share (%), by Therapeutic Area, 2025
  • Figure 16: North America Clinical Trial Supplies Market Value (USD billion), by End User, 2025 & 2034
  • Figure 17: North America Clinical Trial Supplies Market Value Share (%), by End User, 2025
  • Figure 18: North America Clinical Trial Supplies Market Value (USD billion), By Country, 2025 & 2034
  • Figure 19: North America Clinical Trial Supplies Market Value Share (%), By Country, 2025
  • Figure 20: Europe Clinical Trial Supplies Market Value (USD billion), by Type, 2025 & 2034
  • Figure 21: Europe Clinical Trial Supplies Market Value Share (%), by Type, 2025
  • Figure 22: Europe Clinical Trial Supplies Market Value (USD billion), by Phase, 2025 & 2034
  • Figure 23: Europe Clinical Trial Supplies Market Value Share (%), by Phase, 2025
  • Figure 24: Europe Clinical Trial Supplies Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 25: Europe Clinical Trial Supplies Market Value Share (%), by Modality, 2025
  • Figure 26: Europe Clinical Trial Supplies Market Value (USD billion), by Therapeutic Area, 2025 & 2034
  • Figure 27: Europe Clinical Trial Supplies Market Value Share (%), by Therapeutic Area, 2025
  • Figure 28: Europe Clinical Trial Supplies Market Value (USD billion), by End User, 2025 & 2034
  • Figure 29: Europe Clinical Trial Supplies Market Value Share (%), by End User, 2025
  • Figure 30: Europe Clinical Trial Supplies Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe Clinical Trial Supplies Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Asia Pacific Clinical Trial Supplies Market Value (USD billion), by Type, 2025 & 2034
  • Figure 33: Asia Pacific Clinical Trial Supplies Market Value Share (%), by Type, 2025
  • Figure 34: Asia Pacific Clinical Trial Supplies Market Value (USD billion), by Phase, 2025 & 2034
  • Figure 35: Asia Pacific Clinical Trial Supplies Market Value Share (%), by Phase, 2025
  • Figure 36: Asia Pacific Clinical Trial Supplies Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 37: Asia Pacific Clinical Trial Supplies Market Value Share (%), by Modality, 2025
  • Figure 38: Asia Pacific Clinical Trial Supplies Market Value (USD billion), by Therapeutic Area, 2025 & 2034
  • Figure 39: Asia Pacific Clinical Trial Supplies Market Value Share (%), by Therapeutic Area, 2025
  • Figure 40: Asia Pacific Clinical Trial Supplies Market Value (USD billion), by End User, 2025 & 2034
  • Figure 41: Asia Pacific Clinical Trial Supplies Market Value Share (%), by End User, 2025
  • Figure 42: Asia Pacific Clinical Trial Supplies Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Clinical Trial Supplies Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 44: Latin America Clinical Trial Supplies Market Value (USD billion), by Type, 2025 & 2034
  • Figure 45: Latin America Clinical Trial Supplies Market Value Share (%), by Type, 2025
  • Figure 46: Latin America Clinical Trial Supplies Market Value (USD billion), by Phase, 2025 & 2034
  • Figure 47: Latin America Clinical Trial Supplies Market Value Share (%), by Phase, 2025
  • Figure 48: Latin America Clinical Trial Supplies Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 49: Latin America Clinical Trial Supplies Market Value Share (%), by Modality, 2025
  • Figure 50: Latin America Clinical Trial Supplies Market Value (USD billion), by Therapeutic Area, 2025 & 2034
  • Figure 51: Latin America Clinical Trial Supplies Market Value Share (%), by Therapeutic Area, 2025
  • Figure 52: Latin America Clinical Trial Supplies Market Value (USD billion), by End User, 2025 & 2034
  • Figure 53: Latin America Clinical Trial Supplies Market Value Share (%), by End User, 2025
  • Figure 54: Latin America Clinical Trial Supplies Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 55: Latin America Clinical Trial Supplies Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 56: Middle East & Africa Clinical Trial Supplies Market Value (USD billion), by Type, 2025 & 2034
  • Figure 57: Middle East & Africa Clinical Trial Supplies Market Value Share (%), by Type, 2025
  • Figure 58: Middle East & Africa Clinical Trial Supplies Market Value (USD billion), by Phase, 2025 & 2034
  • Figure 59: Middle East & Africa Clinical Trial Supplies Market Value Share (%), by Phase, 2025
  • Figure 60: Middle East & Africa Clinical Trial Supplies Market Value (USD billion), by Modality, 2025 & 2034
  • Figure 61: Middle East & Africa Clinical Trial Supplies Market Value Share (%), by Modality, 2025
  • Figure 62: Middle East & Africa Clinical Trial Supplies Market Value (USD billion), by Therapeutic Area, 2025 & 2034
  • Figure 63: Middle East & Africa Clinical Trial Supplies Market Value Share (%), by Therapeutic Area, 2025
  • Figure 64: Middle East & Africa Clinical Trial Supplies Market Value (USD billion), by End User, 2025 & 2034
  • Figure 65: Middle East & Africa Clinical Trial Supplies Market Value Share (%), by End User, 2025
  • Figure 66: Middle East & Africa Clinical Trial Supplies Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Clinical Trial Supplies Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 68: Global Clinical Trial Supplies Market Share (%), By Company, 2025